LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us
  • EN
  • FR

Tag: Op-Ed

07/12/2024

Cleveland Plains Dealer: Cancer Moonshot Requires More than Money 

Few challenges loom larger for humanity than the fight against cancer. Cancer is an adversary that demands an approach that harnesses the latest technology and the best instincts of the...
READ THE ARTICLE

Posts navigation

Newer posts

Recent Posts

  • Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge
  • Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding
  • Cleveland Business Journal: Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds
  • SIGNIFICANT NIH GRANT WILL HELP LAMASSU BIOTECH ADVANCE LIFE-SAVING PANCREATITIS TREATMENT FOR DOGS
  • LAMASSU BIOTECH COLLABORATES WITH THE OHIO STATE UNIVERSITY TO STUDY NEW THERAPY FOR MAN AND MAN’S BEST FRIEND

Recent Comments

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies